Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Slides:

Advertisements

Similar presentations

Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.

Advertisements

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 1. Baseline Characteristics of the 36,636 Study Subjects

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;

Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting Program Yves Longtin, Sylvie.

Table 1 Characteristics of the 968 Women in the Study Group

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.

From: Clinical and Laboratory Diagnosis of Dengue Virus Infection

From: Rotarix: A Rotavirus Vaccine for the World

Laboratory diagnosis and biosafety issues of biological warfare agents

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

From: Postinfectious Irritable Bowel Syndrome

Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012 M. Tvede,

Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,

Figure 2 In situ hybridization for rhinovirus type 14 (rhinovirus-14) in maxillary sinus biopsy specimens. A, Detection of rhinovirus-14, antisense probe,

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.

Figure 1 Flow chart distinguishing groups according to receipt of azithromycin treatment and method of data collection. Circles containing the abbreviation.

Characteristics of Clostridium difficile strains isolated from asymptomatic individuals and from diarrheal patients S. Wongwanich, P. Pongpech, C. Dhiraputra,

Comparison of polymerase chain reaction and pp65 antigen test for early detection of human cytomegalovirus in blood leukocytes of cardiac transplant recipients

Direct detection of verotoxin genes in stool samples by polymerase chain reaction in hemolytic uremic syndrome patients in France Patricia Mariani-Kurkdjian,

L. Boyanova Clinical Microbiology and Infection

Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction O. Kupferschmidt, D. Krüger, T.K. Held, H. Ellerhrok,

Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program A.-R. Prusa, D.C. Kasper,

Approach to diagnosis of infective endocarditis

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

F. Barbut, M. Delmée, J. S. Brazier, J. C. Petit, I. R. Poxton, M

Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland

New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Comparison of microscopy, real-time PCR and a rapid immunoassay for the detection of Giardia lamblia in human stool specimens T. Schuurman, P. Lankamp,

Comparison of polymerase chain reaction and pp65 antigen test for early detection of human cytomegalovirus in blood leukocytes of cardiac transplant recipients

Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm C. Beaulieu, L.-L.

Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012– 2014: prospective, repeated cross-sectional study L. Furuya-Kanamori,

Viruses detected by systematic multiplex polymerase chain reaction in adults with suspected community-acquired pneumonia attending emergency departments.

L. Gatta, C. Ricci, A. Tampieri, D. Vaira

E. Bouza, P. Muñoz, R. Alonso Clinical Microbiology and Infection

Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients S. Erb, R. Frei,

F. Barbut, L. Surgers, C. Eckert, B. Visseaux, M. Cuingnet, C

Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay P. Jokela,

Laboratory diagnosis and biosafety issues of biological warfare agents

M.H. Wilcox Clinical Microbiology and Infection

L. Fenner, A. F. Widmer, A. Stranden, M. Conzelmann, A. Goorhuis, C

Mathematical modeling of Clostridium difficile infection

Application of Nuclear Magnetic Resonance to Detect Toxigenic Clostridium difficile from Stool Specimens Paul Yang, Sara Hash, Katherine Park, Charlene.

Laboratory diagnosis of Clostridium difficile disease

R. Alonso, C. Muñoz, T. Peláez, E. Cercenado, M. Rodríguez-Creixems, E

Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples J. Stahlmann,

N. Jazmati, M. Hellmich, B. Ličanin, G. Plum, A.J. Kaasch

E.J. Kuijper, B. Coignard, P. Tüll Clinical Microbiology and Infection

How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex.

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Evaluation of the performance of the Helico Blot 2

S. Alexiou-Daniel, A. Stylianakis, A. Papoutsi, I. Zorbas, A. Papa, A

C.P. Kelly Clinical Microbiology and Infection

Abstracts Clinical Microbiology and Infection

Q Fever: Epidemiology, Diagnosis, and Treatment

Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey A. Adler, Y.

Three years experience of real-time PCR for the diagnosis of Q fever

Typing of Clostridium difficile

Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea Michael S. Morelli, Susan.

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Presentation transcript:

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation 2. From: Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea Clin Infect Dis. 2007;45(9):1152-1160. doi:10.1086/522185 Clin Infect Dis | © 2007 by the Infectious Diseases Society of America

Table 4 Results of tests of 370 nonformed stool samples to detect toxigenic Clostridium difficile or its toxins. From: Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea Clin Infect Dis. 2007;45(9):1152-1160. doi:10.1086/522185 Clin Infect Dis | © 2007 by the Infectious Diseases Society of America

Table 3 Results of tests performed on stool samples from 228 patients with clinically significant diarrhea to detect the presence of toxigenic Clostridium difficile or its toxins. From: Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea Clin Infect Dis. 2007;45(9):1152-1160. doi:10.1086/522185 Clin Infect Dis | © 2007 by the Infectious Diseases Society of America

Table 2 Test results for the comparison analysis using the 2 reference standards for the diagnosis of Clostridium difficile-associated diarrhea (CDAD). From: Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea Clin Infect Dis. 2007;45(9):1152-1160. doi:10.1086/522185 Clin Infect Dis | © 2007 by the Infectious Diseases Society of America

Figure 1 Clinical scoring criteria used in prospective patient evaluation From: Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea Clin Infect Dis. 2007;45(9):1152-1160. doi:10.1086/522185 Clin Infect Dis | © 2007 by the Infectious Diseases Society of America

Table 1 Procedure for real-time PCR testing for detection of Clostridium difficile. From: Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea Clin Infect Dis. 2007;45(9):1152-1160. doi:10.1086/522185 Clin Infect Dis | © 2007 by the Infectious Diseases Society of America

Table 6 Clinical needs for accurate testing for Clostridium difficile-associated diarrhea (CDAD). From: Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea Clin Infect Dis. 2007;45(9):1152-1160. doi:10.1086/522185 Clin Infect Dis | © 2007 by the Infectious Diseases Society of America